Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Kelly

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
BMJ (Clinical Research Ed.)|March 15, 2015
Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trialDavid L Scott, Fowzia Ibrahim, Vern Farewell, et al.
Paediatrics and International Child Health|April 22, 2022
The spectrum and burden of in-patient paediatric musculoskeletal diseases in Northern TanzaniaRebecca B Walsh, Anthony Mwingwa, Nateiya M Yongolo, et al.
The Pan African Medical Journal|April 8, 2024
Estimating the prevalence and predictors of musculoskeletal disorders in Tanzania: a cross-sectional pilot studyNateiya Mmeta Yongolo, Jo Halliday, Christopher Bunn, et al.
BMJ Open|January 17, 2025
Economic burden of musculoskeletal disorders in Tanzania: results from a community-based surveyManuela Deidda, Eleanor Grieve, Stefanie Krauth, et al.
BMC Pulmonary Medicine|November 1, 2024
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological diseaseManjit K Cartlidge, Kevin K Brown, Nazia Chaudhuri, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD TrialEric L Matteson, Clive Kelly, Jörg H W Distler, et al.
BMJ Open|December 3, 2025
How do musculoskeletal disorders impact on quality of life in Tanzania? Results from a community-based surveyEleanor Grieve, Manuela Deidda, Stefanie J Krauth, et al.
Rheumatology Advances in Practice|May 20, 2024
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scopeJennifer Hannah, Mia Rodziewicz, Puja Mehta, et al.
The Lancet. Respiratory Medicine|June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statementJoshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
BMJ (Clinical Research Ed.)|March 15, 2015
Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trialDavid L Scott, Fowzia Ibrahim, Vern Farewell, et al.
Paediatrics and International Child Health|April 22, 2022
The spectrum and burden of in-patient paediatric musculoskeletal diseases in Northern TanzaniaRebecca B Walsh, Anthony Mwingwa, Nateiya M Yongolo, et al.
The Pan African Medical Journal|April 8, 2024
Estimating the prevalence and predictors of musculoskeletal disorders in Tanzania: a cross-sectional pilot studyNateiya Mmeta Yongolo, Jo Halliday, Christopher Bunn, et al.
BMJ Open|January 17, 2025
Economic burden of musculoskeletal disorders in Tanzania: results from a community-based surveyManuela Deidda, Eleanor Grieve, Stefanie Krauth, et al.
BMC Pulmonary Medicine|November 1, 2024
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological diseaseManjit K Cartlidge, Kevin K Brown, Nazia Chaudhuri, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD TrialEric L Matteson, Clive Kelly, Jörg H W Distler, et al.
BMJ Open|December 3, 2025
How do musculoskeletal disorders impact on quality of life in Tanzania? Results from a community-based surveyEleanor Grieve, Manuela Deidda, Stefanie J Krauth, et al.
Rheumatology Advances in Practice|May 20, 2024
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scopeJennifer Hannah, Mia Rodziewicz, Puja Mehta, et al.
The Lancet. Respiratory Medicine|June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statementJoshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Pageof 4